[Federal Register Volume 62, Number 81 (Monday, April 28, 1997)]
[Notices]
[Pages 22950-22951]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-10826]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[INFO-97-10]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer on (404) 639-7090.
Comments are invited on: (a) Whether the proposed collection of
information
[[Page 22951]]
is necessary for the proper performance of the functions of the agency,
including whether the information shall have practical utility; (b) the
accuracy of the agency's estimate of the burden of the proposed
collection of information; (c) ways to enhance the quality, utility,
and clarity of the information to be collected; and (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques for other
forms of information technology. Send comments to Wilma Johnson, CDC
Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA
30333. Written comments should be received within 60 days of this
notice.
Proposed Projects
1. A Survey to Assess The Knowledge, Attitudes And Practices of
Health Care Providers Serving Pregnant Women Regarding HIV Counseling
and Testing and the Use Of Zidovudine (ZDV) During Pregnancy--New--This
is a new data collection. The purpose of this survey is to assess the
knowledge, attitudes, and practices of health care providers serving
pregnant women regarding HIV counseling and testing and use of ZDV
during pregnancy. Data will be collected and reported to CDC to
describe: (1) Providers' current practices in providing prenatal care
to HIV-infected women, offering HIV counseling and testing to pregnant
women, and offering ZDV to HIV-infected pregnant women; (2) providers'
knowledge of the ACTG 076 results and PHS perinatal transmission
guidelines; (3) providers' attitudes regarding HIV counseling and
testing of pregnant women; and, (4) providers' knowledge and experience
in the use of ZDV in treating HIV-infected pregnant women.
The intended population to be studied is physicians and nurse-
midwives providing prenatal care in four areas (State of Connecticut,
potential population approximately 685; State of North Carolina,
potential population approximately 1,500; Dade County, FL, potential
population approximately 500; Brooklyn, NY, potential population
approximately 260) where institutions are currently conducting a CDC-
funded study related to implementation of the PHS guidelines to prevent
perinatal transmission of HIV. The total estimated cost to respondents
is $40,370.
----------------------------------------------------------------------------------------------------------------
Number of
Number of responses/ Total burden
Respondents respondents respondent (in hrs.)
(in hrs.)
----------------------------------------------------------------------------------------------------------------
Census: Secretaries............................................ 2,800 1 46
Census: Midwives............................................... 350 1 6
Pilot: Midwives................................................ 15 1 2.5
Pilot: Doctors................................................. 240 1 40
Survey: Midwives............................................... 350 1 58.3
Survey: Doctors................................................ 2,000 1 333.3
------------------------------------------------
Total...................................................... .............. .............. 486.1
----------------------------------------------------------------------------------------------------------------
Dated: April 22, 1997.
Wilma G. Johnson,
Acting Associate Director for Policy Planning and Evaluation, Centers
for Disease Control and Prevention (CDC).
[FR Doc. 97-10826 Filed 4-25-97; 8:45 am]
BILLING CODE 4163-18-P
